Maker Of Botox Is Sold To AbbVie In $63 Billion Deal
The drugmaker AbbVie, owner of the top-selling drug Humira, announced on Tuesday, June 25, it will buy Allergan for $63… Read more »
The drugmaker AbbVie, owner of the top-selling drug Humira, announced on Tuesday, June 25, it will buy Allergan for $63… Read more »